Search

Author/Creator Bruno, Jennifer

1. CTNI-05. PRELIMINARY RESULTS OF THE NERATINIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (12th November 2021)

Authors:
Arrillaga-Romany, Isabel; Trippa, Lorenzo; Fell, Geffrey; Lee, Eudocia Quant; Rahman, Rifaquat; Touat, Mehdi; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE. (12th November 2021)

Authors:
Rahman, Rifaquat; Trippa, Lorenzo; Lee, Eudocia Quant; Arrillaga-Romany, Isabel; Touat, Mehdi; Fell, Geffrey; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei...
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 2 and biomarker study of trebananib, an angiopoietin‐blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma. Issue 7 (19th December 2017)

Authors:
Reardon, David A.; Lassman, Andrew B.; Schiff, David; Yunus, Shakeeb A.; Gerstner, Elizabeth R.; Cloughesy, Timothy F.; Lee, Eudocia Quant; Gaffey, Sarah C.; Barrs, Jennifer; Bruno, Jennifer; Muzikansky, Alona; Duda, Daniel G.; Jain, Rakesh K.; Wen, Patrick Y.
Journal:
Cancer
Issue:
Volume 124:Issue 7(2018)
Page Start:
1438
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma. (24th August 2019)

Authors:
Lee, Eudocia Q.; Muzikansky, Alona; Duda, Dan G.; Gaffey, Sarah; Dietrich, Jorg; Nayak, Lakshmi; Chukwueke, Ugonma N.; Beroukhim, Rameen; Doherty, Lisa; Laub, Caroline Kane; LaFrankie, Debra; Fontana, Brittney; Stefanik, Jennifer; Ruland, Sandra; Caruso, Victoria; Bruno, Jennifer; Ligon, Keith; R...
Journal:
Cancer medicine
Issue:
Volume 8:Number 13(2019:Oct.)
Page Start:
5988
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗